F. Mitjavila

发表

Patient Registries of Acute Coronary Syndrome: Assessing or Biasing the Clinical Real World Data?

H. Bueno, J. Marrugat, J. Marsal, 2009, Circulation. Cardiovascular quality and outcomes.

Clinicopathological correlations and prognostic factors in lupus nephritis.

M. Carrera, R. Pujol, F. Mitjavila, 1997, Clinical and experimental rheumatology.

Microscopic pulmonary tumoral embolism and subacute cor pulmonale as the first clinical signs of cancer.

D. Chivite, R. Pujol, F. Mitjavila, 1999, Acta oncologica.

The value of repeat biopsy in lupus nephritis flares

J. Nolla, J. Torras, X. Juanola, 2017, Medicine.

Shrinking lung syndrome in systemic lupus erythematosus

J. Nolla, M. Molina-Molina, H. Borrell, 2016, Medicine.

First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort

G. Espinosa, G. Ruiz-Irastorza, J. Callejas, 2016, Lupus Science & Medicine.

Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.

G. Espinosa, G. Ruiz-Irastorza, J. Callejas, 2016, Clinical and experimental rheumatology.

Bone mineral density and hormonal status in men with systemic lupus erythematosus

R. Bonnin, F. Mitjavila, I. Moga, 1996, Lupus.

Loss of bone mineral density in premenopausal women with systemic lupus erythematosus.

J. Nolla, D. Roig-Escofet, F. Mitjavila, 1995, Annals of the rheumatic diseases.

The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity

A. Blom, S. Rodríguez de Córdoba, J. Torras, 2022, Frontiers in Immunology.

Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor‐associated periodic syndrome due to the R92Q TNFRSF1A variant

J. Aróstegui, X. Corbella, D. Camprubí, 2017, International journal of rheumatic diseases.

Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial

C. Tebé, S. Videla, J. Niubó, 2021, Frontiers in Medicine.

Dual effects of interleukin 4 on antigen‐activated human B cells: induction of proliferation and inhibition of interleukin 2‐dependent differentiation

P. Galanaud, L. Llorente, M. Crevon, 1990, European journal of immunology.

Systemic lupus erythematosus after eosinophilic fasciitis: a case report.

O. Servitje, F. Gallardo, F. Mitjavila, 1998, Journal of the American Academy of Dermatology.

Diffuse non-hydrostatic, non-hypooncotic edema in autoimmune lupus-like disorders.

A. Casanovas, J. Oristrell, D. Chivite, 2001, The American journal of medicine.

Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol

C. Tebé, S. Videla, J. Niubó, 2021, Contemporary Clinical Trials Communications.

Chronic ascites in late onset systemic lupus erythematosus with antiphospholipid antibodies.

X. Corbella, F. Mitjavila, A. Vidaller, 1994, The Journal of rheumatology.

Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI

F. Formiga, R. Pujol, F. Mitjavila, 1999, Lupus.

High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosus.

R. Pujol, F. Mitjavila, I. Moga, 1999, Rheumatology.

Granulomatous mastitis associated with erythema nodosum: A case series of 42 patients

R. Penin, J. Marcoval, F. Mitjavila, 2022, Medicina Clínica (English Edition).

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

M. Gasa, A. Ariza-Solé, J. Sabater, 2020, International Journal of Infectious Diseases.

Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.

G. Espinosa, G. Ruiz-Irastorza, L. Iaccarino, 2020, Clinical and Experimental Rheumatology.

Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial

X. Vidal, L. Sáez-comet, J. Ordi‐Ros, 2017, Annals of the rheumatic diseases.

Clinical characteristics during diagnosis of a prospective cohort of patients with systemic lupus erythematosus treated in Spanish Departments of Internal Medicine: The RELES study.

G. Espinosa, G. Ruiz-Irastorza, J. Canora, 2017, Revista clinica espanola.

Salivary testosterone during the menstrual cycle in women with systemic lupus erythematosus

M. Bonnín, F. Mitjavila, A. Vidaller, 1997, Lupus.

Predicting in-hospital mortality with coronary bypass surgery using hospital discharge data: comparison with a prospective observational study.

J. Marsal, I. Ferreira-González, G. Permanyer-Miralda, 2008, Revista espanola de cardiologia.

Patient Registries of Acute Coronary Syndrome: Assessing or Biasing the Clinical Real World Data?

H. Bueno, J. Marrugat, J. Marsal, 2009, Circulation. Cardiovascular quality and outcomes.

Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients

F. Mitjavila, I. Moga, F. Formiga, 1997, Lupus.

Photosensitivity and Autoantibodies to Sm, Ro, and La in a Patient with Silicosis

J. Peyri, F. Mitjavila, G. Sais, 1996, International journal of dermatology.

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients

G. Espinosa, Ming-Chi Lu, B. Pinilla, 2023, Medicina.